Factor VIIa (Recombinant) and Hydrochlorothiazide and lisinopril
Determining the interaction of Factor VIIa (Recombinant) and Hydrochlorothiazide and lisinopril and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: Coagulation factor VIIa (injection)
Generic Name: hydrochlorothiazide / lisinopril
Brand name: Zestoretic, Prinzide
Synonyms: Lisinopril and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Factor VIIa (Recombinant)-Hydrochlorothiazide and losartan
- Factor VIIa (Recombinant)-Hydrochlorothiazide and methyldopa
- Factor VIIa (Recombinant)-Hydrochlorothiazide and metoprolol
- Factor VIIa (Recombinant)-Hydrochlorothiazide and moexipril
- Factor VIIa (Recombinant)-Hydrochlorothiazide and olmesartan
- Factor VIIa (Recombinant)-Hydrochlorothiazide and propranolol
- Hydrochlorothiazide and lisinopril-Factor X (Human)
- Hydrochlorothiazide and lisinopril-Factor x human Intravenous
- Hydrochlorothiazide and lisinopril-Factor XIII
- Hydrochlorothiazide and lisinopril-Factor XIII (Human)
- Hydrochlorothiazide and lisinopril-Factor XIII A-Subunit (Recombinant)
- Hydrochlorothiazide and lisinopril-Factor XIII Concentrate (Human)